Defunct Company
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
238
NCT01474382
Study of OraVerse® for Safety and Efficacy in Pediatric Dental Patients
Phase: Phase 4
Role: Lead Sponsor
Start: Feb 29, 2012
Completion: Aug 31, 2014
NCT01805804
Valsartan to Prevent Left Ventricle Remodeling in Pacemaker Patients
Role: Collaborator
Start: Jan 31, 2017
Completion: Jan 31, 2019